MARKET

RIGL

RIGL

Rigel Pharms
NASDAQ

Real-time Quotes | Nasdaq Last Sale

2.270
-0.040
-1.73%
Closed 16:00 11/12 EST
OPEN
2.320
PREV CLOSE
2.310
HIGH
2.410
LOW
2.255
VOLUME
1.32M
TURNOVER
--
52 WEEK HIGH
3.160
52 WEEK LOW
1.560
MARKET CAP
380.48M
P/E (TTM)
-8.1743
1D
5D
1M
3M
1Y
5Y

Buy or sell shares of RIGL and other stocks commission-free!

Open a Webull account and fund it to get a free stock

Analyst Rating

Based on 7 analysts

Buy

Disclaimer: The analysis information is for reference only and does not constitute an investment recommendation.

EPS

RIGL News

  • Rigel to Present at Jefferies 2019 London Healthcare Conference
  • PR Newswire.1h ago
  • Pharma Sector Tops in October: Best ETFs & Stocks
  • Zacks.5d ago
  • Rigel Pharmaceuticals, Inc. (RIGL) CEO Raul Rodriguez on Q3 2019 Results - Earnings Call Transcript
  • Seeking Alpha - Transcript.5d ago
  • Rigel Announces Upcoming Data Presentations at the 61st ASH Annual Meeting & Exposition
  • PR Newswire.6d ago

More

Industry

Biotechnology & Medical Research
+0.28%
Pharmaceuticals & Medical Research
+0.27%

Hot Stocks

Name
Price
%Change

About RIGL

Rigel Pharmaceuticals, Inc., is a clinical-stage biotechnology company. The Company is engaged in discovering, developing and providing novel small molecule drugs that improve the lives of patients with immune and hematological disorders, cancer and rare diseases. The Company’s research focuses on signaling pathways that are critical to disease mechanisms. The Company’s product include TAVALISSE is an oral spleen tyrosine kinase (SYK) inhibitor for the treatment of adult patients with chronic immune thrombocytopenia (ITP). Its current clinical programs include Phase 2 studies of fostamatinib in autoimmune hemolytic anemia and IgA nephropathy, and a Phase I study for its interleukin receptor associated kinase (IRAK) program. In addition, it has product candidates in development with partners BerGenBio AS, Daiichi Sankyo and Aclaris Therapeutics.
More

Webull offers Rigel Pharmaceuticals, Inc. (RIGL) stock price, real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, stock news, and many more online research tools to help you make informed decisions.